Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Key Developments in Obesity Medicine in 2023: An Expert Discussion
Angela Fitch, MD, president of the Obesity Medicine Association discusses key pharmaceutical and research developments in obesity medicine in 2023.
"What are the most important pharmaceutical and/or research developments in weight management and obesity medicine in 2023?"
Was a question Patient Care Online asked Angela Fitch, MD, president of the Obesity Medicine Association, in a recent interview. In the video below, Dr Fitch discusses advancements in the nutrient-stimulated hormone category of drug therapy for obesity; the release of tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) hormone mimetic; and more.
Dr Fitch is also the founder and chief medical officer at knownwell and the former co-director of the Massachusetts General Hospital Weight Center and faculty at Harvard Medical School.
Recent Videos
